About: Toshiro Inaba

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Toshiro Inaba Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Japanese physician

Attributes	Values
rdf:type	Item
description	Jaapani arst (et) Japanese physician (en) medic japonez (ro) metge japonès (ca) mjek japonez (sq) médecin japonais (fr) médico japonés (es) médico xaponés (gl) רופא יפני (he) طبيب ياباني (ar) জাপানি চিকিৎসক (bn) 日本の医師 (ja)
rdfs:label	Toshiro Inaba (en) Toshiro Inaba (nl) Toshiro Inaba (tr) Toshiro Inaba (ast) 稲葉俊郎 (ja)
skos:prefLabel	Toshiro Inaba (en) Toshiro Inaba (nl) Toshiro Inaba (tr) Toshiro Inaba (ast) 稲葉俊郎 (ja)
name	Toshiro Inaba (en) Toshiro Inaba (nl) Toshiro Inaba (tr) Toshiro Inaba (ast) 稲葉俊郎 (ja)
name in kana	wds:Q30925076-4bafcce6-5612-405c-98f4-c06895ccd6ef
name in kana	いなばとしろう
instance of	wds:Q30925076-F227531F-153D-4EB6-B6CF-DEF4DD22DD53
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q30925076-C2143F25-C46F-435E-BC91-0184FC04692B
Google Knowledge Graph ID	http://g.co/kg/g/11g6rd0mk2
Google Knowledge Graph ID	/g/11g6rd0mk2
sex or gender	wds:Q30925076-87b978cc-4370-e5a4-8e5d-e8e59adb2aea
VIAF ID	wds:Q30925076-7e1dc086-42ea-5393-5856-0122420071bd
country of citizenship	wds:Q30925076-D6154EF2-7DC6-4FCA-8D4A-BF047D43E822
NDL Authority ID	wds:Q30925076-9767CECC-0A18-4F11-A0F6-EA4C1F459E80
educated at	wds:Q30925076-D290C911-1F03-48FB-9113-D41BAB610699
family name	wds:Q30925076-A2E770E5-F9AF-4DE7-8214-58183DCBBC34
WorldCat Identities ID (superseded)	wds:Q30925076-EBE33D3A-A90F-46F4-9A0D-6E9D3CA64A10
VIAF ID	http://viaf.org/viaf/117150746931716300402
NDL Authority ID	http://id.ndl.go.jp/auth/ndlna/001272825
sex or gender	male
VIAF ID	117150746931716300402
country of citizenship	Japan
NDL Authority ID	001272825
educated at	University of Tokyo
family name	Inaba
WorldCat Identities ID (superseded)	viaf-117150746931716300402
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q30925076 https://ja.wikipedia.org/wiki/%E7%A8%B2%E8%91%89%E4%BF%8A%E9%83%8E
is author of	Successful treatment of hemodynamic compromise caused by antibody-mediated and cellular rejection in a recipient 12 years after heart transplantation Introns in protein-coding genes in Archaea Novel risk scoring system with preoperative objective parameters gives a good prediction of 1-year mortality in patients with a left ventricular assist device. Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device Preoperative beta-blocker treatment is a key for deciding left ventricular assist device implantation strategy as a bridge to recovery. Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support Recipients with shorter cardiopulmonary bypass time achieve improvement of parasympathetic reinnervation within 6 months after heart transplantation Parasympathetic reinnervation accompanied by improved post-exercise heart rate recovery and quality of life in heart transplant recipients. Lower rotation speed stimulates sympathetic activation during continuous-flow left ventricular assist device treatment. Late rejection occurred in recipients who experienced acute cellular rejection within the first year after heart transplantation Bosentan improved persistent pulmonary hypertension in a case after implantation of a left ventricular assist device Opening of native aortic valve accomplished after left ventricular assist device implantation in patients with insufficient preoperative Beta-blocker treatment Quality of Life and Influential Factors in Patients Implanted With a Left Ventricular Assist Device. A case with recovery of response to tolvaptan associated with remission of acute kidney injury and increased urine osmolality Successful Conversion From Thiazide to Tolvaptan in a Patient With Stage D Heart Failure and Chronic Kidney Disease Before Heart Transplantation Novel Scoring System to Predict Ineligibility for Bridge to Implantable Left Ventricular Assist Device as Destination Therapy Before Extracorporeal Ventricular Assist Device Implantation - For the Coming Era of Destination Therapy in Japan Tolvaptan can improve clinical course in responders. Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device Low cardiac output stimulates vasopressin release in patients with stage d heart failure. Everolimus-incorporated immunosuppressant strategy improves renal dysfunction while maintaining low rejection rates after heart transplantation in Japanese patients. Intravascular ultrasound, angioscopic and histopathological characterisation of heterogeneous patterns of restenosis after sirolimus-eluting stent implantation: insights into potential "thromborestenosis" phenomenon Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation. Preoperative levels of bilirubin or creatinine adjusted by age can predict their reversibility after implantation of left ventricular assist device Is the internal jugular vein or femoral vein a better approach site for endomyocardial biopsy in heart transplant recipients? Status 2 patients had poor prognosis without mechanical circulatory support Novel scoring system using cardiopulmonary exercise testing predicts prognosis in heart failure patients receiving guideline-directed medical therapy. A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation. Urine osmolality estimated using urine urea nitrogen, sodium and creatinine can effectively predict response to tolvaptan in decompensated heart failure patients Low Blood Pressure, Low Serum Cholesterol and Anemia Predict Early Necessity of Ventricular Assist Device Implantation in Patients With Advanced Heart Failure at the Time of Referral From Non-Ventricular Assist Device Institutes. An Experience of Landiolol Use for an Advanced Heart Failure Patient With Severe Hypotension. Correction of hyponatremia by tolvaptan before left ventricular assist device implantation. Trend of clinical outcome and surrogate markers during titration of β-blocker in heart failure patients with reduced ejection fraction: relevance of achieved heart rate and β-blocker dose The potential of RF backscattered IVUS data and multidetector-row computed tomography images for tissue characterization of human coronary atherosclerotic plaques Targeted therapy is required for management of pulmonary arterial hypertension after defect closure in adult patients with atrial septal defect and associated pulmonary arterial hypertension Low blood pressure, low serum cholesterol and anemia predict early necessity of ventricular assist device implantation in patients with advanced heart failure at the time of referral from non-ventricular assist device institutes Is Achieved Heart Rate a Surrogate Maker during Titration of Beta-blocker in Heart Failure with Atrial Fibrillation? Novel scoring system using postoperative cardiopulmonary exercise testing predicts future explantation of left ventricular assist device
is author of	wds:Q39015143-BCD89CFD-DA47-428F-9AE5-05F57F32539A wds:Q41072066-C3A7F70D-AC33-4F6A-800A-91CA5685A6BE wds:Q54484827-77FF7D4F-AAAA-46B6-9548-8E7746E534A6 wds:Q50620299-15A04CC7-7AAA-4DE1-A980-685CF7C62947 wds:Q51792635-B5AABA42-D10E-4EDC-897E-A9A078EA2628 wds:Q34106477-BFFC2B9B-281F-41EE-BD43-39D64F4DEB16 wds:Q44361627-29A6D518-2AC9-45C4-904D-6BF491D1B055 wds:Q45298659-38D98B5A-9542-40F6-B386-B36580041A23 wds:Q44545969-73B501A8-935B-46BB-A195-AF7D6C927B39

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software